Document Detail

Cardioprotection of 17,18-epoxyeicostetraenoic Acid in ischemia/reperfusion is mediated by cyclooxygenase-2: a study in a rat model.
MedLine Citation:
PMID:  21693227     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND/PURPOSE: Arachidonic acid and related cardioprotective eicosanoids are released in myocardial ischemia/reperfusion injury. The present study analyzes the effects of the eicosapentaenoic acid derived 17,18-epoxyeicostetraenoic acid on isolated cardiomyocytes and investigates whether 17,18-epoxyeicostetraenoic acid serves as a potential factor in the cardio-depressant postischemic effluent.
BASIC PROCEDURES: After 10 minutes of global ex vivo stop-flow ischemia, adult rat hearts were reperfused and coronary postischemic effluent was collected over a period of 30 seconds. Nonischemic effluent was collected prior to ischemia. The effects of 17,18-epoxyeicostetraenoic acid on calcium (Ca(2+)) metabolism and contraction frequency of isolated neonatal rat cardiomyocytes were tested and compared with the effects of prior collected postischemic and nonischemic effluents. Isolated neonatal cardiomyocytes were preincubated with selective (NS-398, SC-560) and nonselective cyclooxygenase inhibitors (indomethacin) to determine whether cardio-depressive effects are mediated by cyclooxygenase.
FINDINGS: In contrast to the nonischemic effluent, both 17,18-epoxyeicostetraenoic acid and the postischemic effluent induced a comparable decrease of the Ca(2+) transient and the contraction frequency (P < .05 vs control). The cardio-depressive effects of 17,18-epoxyeicostetraenoic acid and the postischemic effluent were significantly attenuated after preincubation with the unselective cyclooxygenase inhibitor indomethacin and the selective cyclooxygenase-2 inhibitor NS-398 (P < .05 vs control). Selective cyclooxygenase-1 inhibition with SC-560 did not influence the effect of 17,18-epoxyeicostetraenoic acid and the postischemic effluent.
CONCLUSIONS: Our data show that the cardio-depressive effects of 17,18-epoxyeicostetraenoic acid are comparable with the postischemic effluent and are mediated by cyclooxygenase-2. Our results suggest a potential cardioprotective role of the eicosanoid 17,18-epoxyeicostetraenoic acid in heart ischemia/reperfusion injury.
M Schmelzle; S B Felix; A Staudt; L R Herda
Related Documents :
1134847 - Diamino acid transport into granulocytes and liver slices of patients with lysinuric pr...
2318817 - Expression of the hepatocyte na+/bile acid cotransporter in xenopus laevis oocytes.
7511427 - An experimental model of hypoxia on isolated rat heart in recirculating system: study o...
15591587 - Treatment of suckling rats with glp-2 plus dexamethasone increases the ileal uptake of ...
7199007 - Enhancement of the antitumor effect of 6-mercaptopurine by vitamin a.
9700927 - Amino acid sequence and d/l-configuration determination of peptides utilizing liberated...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Transplantation proceedings     Volume:  43     ISSN:  1873-2623     ISO Abbreviation:  Transplant. Proc.     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-06-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0243532     Medline TA:  Transplant Proc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1515-9     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Department of Internal Medicine B, Ernst-Moritz-Arndt-University, Greifswald, Germany; Department of Gastroenterology, The Transplant Institute, Beth Israel Deaconess Medical Center, Harvard University, Boston, Massachusetts, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Factors influencing rat survival in a warm renal ischemia model: time to adapt the protocols.
Next Document:  Comparing the performance of rat lungs preserved for 6 or 12 hours after perfusion with low-potassiu...